Comparing 4.0 mg.Kg-1 Sugammadex With Placebo in the Reversal of Profound Neuromuscular Blockade (P05767)

NCT00758485 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

140

Enrollment

INDUSTRY

Sponsor class

Conditions

Anesthesia
Neuromuscular Blockade

Interventions

DRUG: Sugammadex
DRUG: 0.9% sodium chloride (NaCl)

Sponsor

Merck Sharp & Dohme LLC